1. Home
  2. IPSC vs OMH Comparison

IPSC vs OMH Comparison

Compare IPSC & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • OMH
  • Stock Information
  • Founded
  • IPSC 2019
  • OMH 2015
  • Country
  • IPSC United States
  • OMH Singapore
  • Employees
  • IPSC N/A
  • OMH N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • OMH Real Estate
  • Sector
  • IPSC Health Care
  • OMH Finance
  • Exchange
  • IPSC Nasdaq
  • OMH Nasdaq
  • Market Cap
  • IPSC 43.2M
  • OMH 35.8M
  • IPO Year
  • IPSC 2021
  • OMH 2023
  • Fundamental
  • Price
  • IPSC $0.56
  • OMH $1.27
  • Analyst Decision
  • IPSC Strong Buy
  • OMH Hold
  • Analyst Count
  • IPSC 5
  • OMH 1
  • Target Price
  • IPSC $3.33
  • OMH N/A
  • AVG Volume (30 Days)
  • IPSC 486.6K
  • OMH 284.7K
  • Earning Date
  • IPSC 11-04-2025
  • OMH 09-25-2025
  • Dividend Yield
  • IPSC N/A
  • OMH N/A
  • EPS Growth
  • IPSC N/A
  • OMH N/A
  • EPS
  • IPSC N/A
  • OMH N/A
  • Revenue
  • IPSC $114,128,000.00
  • OMH $7,976,578.00
  • Revenue This Year
  • IPSC $1,589.94
  • OMH $28.40
  • Revenue Next Year
  • IPSC N/A
  • OMH $23.07
  • P/E Ratio
  • IPSC N/A
  • OMH N/A
  • Revenue Growth
  • IPSC 5491.77
  • OMH 117.53
  • 52 Week Low
  • IPSC $0.34
  • OMH $0.59
  • 52 Week High
  • IPSC $1.83
  • OMH $5.10
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 60.86
  • OMH 51.16
  • Support Level
  • IPSC $0.48
  • OMH $1.24
  • Resistance Level
  • IPSC $0.51
  • OMH $1.37
  • Average True Range (ATR)
  • IPSC 0.03
  • OMH 0.08
  • MACD
  • IPSC 0.01
  • OMH -0.00
  • Stochastic Oscillator
  • IPSC 67.79
  • OMH 47.57

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: